Revo NA Bio
RevoNA Bio is a pre-seed stage, female-founded company spun out from the University of Portsmouth, UK. They are revolutionizing RNA-targeted drug discovery by addressing the limitations of current R&D tools and understanding of RNA structure and function. RevoNA's innovative solution utilizes a patented high-throughput RNA biological platform to gather extensive RNA datasets. These datasets feed a machine learning predictive engine, enabling mechanistic elucidation of RNA structure-activity relationships, hit identification and optimization, and safety assessment of compounds. Their platform aims to significantly reduce the cost and time-to-market for RNA-targeted drugs, making the discovery process more affordable and scalable.
Revo NA Bio
RevoNA Bio is a pre-seed stage, female-founded company spun out from the University of Portsmouth, UK. They are revolutionizing RNA-targeted drug discovery by addressing the limitations of current R&D tools and understanding of RNA structure and function. RevoNA's innovative solution utilizes a patented high-throughput RNA biological platform to gather extensive RNA datasets. These datasets feed a machine learning predictive engine, enabling mechanistic elucidation of RNA structure-activity relationships, hit identification and optimization, and safety assessment of compounds. Their platform aims to significantly reduce the cost and time-to-market for RNA-targeted drugs, making the discovery process more affordable and scalable.